| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |